Skip to main content
Humedix Co., Ltd. logo

Humedix Co., Ltd. — Investor Relations & Filings

Ticker · 200670 ISIN · KR7200670008 KO Manufacturing
Open in API
Filings indexed 317 across all filing types
Latest filing 2025-11-10 Notice of Dividend Amou…
Country KR South Korea
Listing KO 200670

About Humedix Co., Ltd.

https://humedix.com/eng/home.php?go=Ame…

Humedix Co., Ltd. is a healthcare company that develops and manufactures biological and pharmaceutical products focused on human health and beauty. The company specializes in hyaluronic acid-based applications, producing medical devices such as dermal fillers and arthritis treatments. Its portfolio also includes prescription medicines, active pharmaceutical ingredients (APIs), and functional cosmetics. Additionally, Humedix offers Contract Manufacturing Organization (CMO) services within the healthcare sector.

Recent filings

Filing Released Lang Actions
현금ㆍ현물배당결정 (분기배당)
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement regarding the decision of a cash and in-kind dividend (quarterly dividend) by the company 휴메딕스. It includes details such as dividend type, amount per share, total dividend amount, record date, payment date, and approval by the board of directors. The document is short (1228 characters) and focuses solely on dividend declaration details without financial statements or broader financial performance data. This matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts and payment details to shareholders.
2025-11-10 Korean
신탁계약해지결과보고서
Regulatory Filings Classification · 95% confidence The document is titled '신탁계약해지결과보고서' which translates to 'Trust Contract Termination Result Report'. It is addressed to the Financial Supervisory Service (금융감독원장 귀하) and details the termination of a trust contract related to the acquisition of treasury shares by the company 휴메딕스. The document includes specific dates, amounts, and shareholding details related to the trust contract termination and the resulting treasury shares held by the company. The content is a detailed report on the termination of a specific financial trust contract and the status of treasury shares, not a general financial report, earnings release, or management discussion. It is not an announcement of a report but the report itself, given the detailed financial and transactional data. This fits best with the category of Regulatory Filings (RNS) as it is a regulatory report on trust contract termination and treasury shares, which does not fit other more specific categories like Annual Report or Earnings Release.
2025-11-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by corporate insiders (directors/executives) to report their personal share transactions, such as stock option exercises and subsequent sales. This corresponds to the 'Director's Dealing' category.
2025-09-10 Korean
[기재정정]현금ㆍ현물배당결정 (중간배당)
Notice of Dividend Amount Classification · 100% confidence The document is a regulatory filing from Humedix regarding a correction to a previously announced cash dividend (interim dividend). It details the change in the total dividend amount due to a change in the number of treasury shares. Since the document specifically announces the dividend amount, payment date, and related details, it falls under the 'Notice of Dividend Amount' category.
2025-08-29 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Humedix, covering the period from January 1, 2025, to June 30, 2025. It contains comprehensive corporate information, including company overview, history, capital structure, shareholding status, and governance details. As it is a formal, comprehensive financial report for a period shorter than a full fiscal year (interim period) and contains substantive financial and operational data, it is classified as an Interim/Quarterly Report. H1 2025
2025-08-14 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling of an Investor Relations (IR) meeting (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. Since this is an announcement of an upcoming event rather than the presentation materials themselves, and it does not fit into the specific report categories, it is classified as a Regulatory Filing (RNS) which serves as the fallback for general corporate announcements of this nature.
2025-08-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.